Guangzhou Concord Cancer Center Surpasses 800 Patients, Reflecting Growing Demand for Precision Radiation Therapy in Asia
As of April 2026, the Proton Therapy Center at Guangzhou Taihe Oncology Hospital has treated more than 800 patients, while daily treatment volume has exceeded 100 proton therapy sessions. Achieved within 16 months of operation, the milestone represents one of the fastest clinical ramp-ups among newly launched proton therapy centers in the region...
Guangzhou Concord Cancer Center Showcases Proton Therapy at Bangladesh Medical Expo, Attracting Strong Interest from South Asia.
Guangzhou Concord Cancer Center participated in the 17th Dhaka International Medical Equipment Exhibition, presenting its proton therapy technology and precision oncology capabilities to healthcare providers and patients from South Asia...
Concord Medical Expands Strategic Collaboration with Mayo Clinic to Build a Comprehensive Health Management Ecosystem.
Concord Medical, a leading oncology-focused healthcare group in China listed on the Hong Kong Stock Exchange (02453.HK), announced today that it has signed a new round of strategic cooperation agreement this month with Mayo Clinic.Building on years of solid collaboration and mutual trust, this agreement marks a new phase in the partnership, expanding its scope from the internationalization and standardization of oncology care to a full lifecycle health service model, encompassing disease prevention, screening, rehabilitation, and long-term health management...
A One-in-a-Million Diagnosis, Treated with Millimeter Precision.
Since mid-March, on weekdays, Rafi (a pseudonym), a young man from Indonesia, has been visiting Guangzhou Concord Cancer Center for proton therapy. Each session lasts around twenty minutes.After treatment, he and his wife often take short walks along a nearby park path, using the time to unwind and step away from the treatment routine...
Proton Therapy Bridges the Silk Road of Health - Guangzhou Concord Cancer Center and Medical Peers from Russia and Kazakhstan Discuss Collaborative Oncology Care.
In April, with spring in full bloom in Guangzhou, against the backdrop of deepening convergence between the "Health Silk Road" initiative and the development of the Guangdong-Hong Kong-Macao Greater Bay Area, Guangzhou Concord Cancer Center (hereinafter referred to as "GCCC") has ushered in another significant moment for deepening international medical cooperation...
Proton Therapy as a Vessel for Global Expansion: Advancing High-Quality Healthcare Overseas and Shaping a New Blueprint for International Medical Tourism | Bangladeshi Medical Delegation Visits Guangzhou Concord Cancer Center
From March 23 to 24, 2026, Guangzhou Concord Cancer Center (GCCC) welcomed a delegation of medical representatives from Bangladesh. This exchange aimed to foster in-depth dialogue on core topics such as precision oncology technologies and international medical service collaboration...
“Absolutely Excellent!” Bangladeshi Lymphoma Patient Gives High Praise to a Guangzhou Hospital
One early morning in March 2026，shortly after 4:30 am., Guangzhou was still enshrouded in darkness. Joyce from the Customer Service Department of Guangzhou Concord Cancer Center(GCCC) had already quietly set out to meet a married couple from afar and were staying at their hotel...
Jointly Advancing a New Chapter of the Health Silk Road │ H.E. the Ambassador of Uzbekistan to China Leads a Delegation on an Official Visit and Exchange
H.E. the Ambassador of Uzbekistan to China and Delegation Visit Guangzhou Concord Cancer Center (GCCC) to Discuss the Future of International Medical Collaboration...
Concord Medical Accelerates Global Strategy with a Dual Engine of “Healthcare + AI,” Building a Compassionate and Connected Medical Ecosystem
On February 11, 2026, Concord Medical Group marked a milestone in its global expansion strategy. Group President Jiang Wei and Qian Chaonan, President of Guangzhou Concord Cancer Center, led a core delegation to formally sign a Memorandum of Cooperation with National Hospital Surabaya, the largest comprehensive hospital in Indonesia’s East Java Province...
Red Ribbon Unveiled, Strategy Upgraded: Concord Medical Partners with Su Fengxi to Advance Breast Cancer Care in Southern China
February 9, 2026 — A moment of both solemnity and celebration was marked in the main lobby of Guangzhou Taihe Oncology Hospital, a flagship hospital under Concord Medical (HKEX: 02453). As the red ribbon was unveiled for the Su Fengxi Breast Cancer Center, the occasion signaled more than an upgrade of breast cancer resources in Southern China...
A Beam of Light，Guarding the Journey of Life：First Anniversary of Proton Center Operations
Since its official opening in December 2024, the Proton Therapy Center of Guangzhou Concord Cancer Center has been operating smoothly for one year. Over the past 365 days, precise proton beams have crossed the boundaries of age, geography, and language, safeguarding patients' life trajectories through a medical practice that balances science and warmth...
Concord Medical Selected Four Times for National Guidelines, Participates in Six “National Standard” Projects
On December 11, 2025, the National Cancer Center, the National Center for Medical Quality Control of Tumor Diseases, and the Radiotherapy Quality Control Expert Committee officially released the “Clinical Practice Guidelines for Ion Radiation Therapy (2025 Edition)”...
Guangzhou Concord Cancer Center Invited to Attend PTCOG-AO 2025 Annual Meeting, Bringing Together Global Leaders in Proton Therapy
Leaders Gather to Advance Proton Therapy: Guangzhou Concord Cancer Center Showcases Its Expertise at PTCOG-AO 2025.Bringing together leading experts from across the globe,the 5th Annual Meeting of the Particle Therapy Co-Operative Group – Asia Oceania (PTCOG-AO 2025) successfully concluded in Hong Kong, China...
Concord Medical President Jasmine Leads Delegation to the U.S. for In-Depth Exchange on Mayo Clinic’s Advanced Care Model
From September 2 to 5, 2025, Jasmine, President of Concord Medical, together with Rayden, Executive Assistant to the President, led an eight-member senior management delegation on an in-depth exchange visit to Mayo Clinic’s Rochester campus in the United States...
Trust Across 7000 Kilometers: An Iraqi Family's Transnational Journey to Proton Therapy
On a sunny afternoon in September 2025, sunlight streamed through the glass dome of Guangzhou Concord Cancer Center's sunken hall, gently falling upon a large drum adorned with red totems. Aron, a young man from Iraq who had just completed his full course of proton therapy, deftly raised his drumsticks and struck the drum with force....
World Book Day | When Words Serve as a Prescription for Healing Life: There Might Be Light within Books
On World Book Day (April 23, 2025), Guangzhou Concord Cancer Center hosted a workshop titled "Combating Cancer with bookish scent, Guarding Life's Light."...
Deepening Bay Area Exchanges to Advance Healthcare Development | Guangzhou Concord Cancer Center Visits Another Premier Hong Kong Medical Institution
On March 17, 2025, Professor Qian Chaonan, President of Guangzhou Concord Cancer Center (GCCC), led a delegation to visit CUHK Medical Centre in Hong Kong, following a prior visit to Hong Kong Sanatorium & Hospital...
Proton therapy: The world's advanced radiotherapy technology
Proton radiotherapy is one of the advanced radiotherapy techniques in the world at present and can be used to treat various complex tumor cases, such as childhood tumors, head and neck tumors, liver cancer and lung cancer...
President Qian And Hospital Representatives Visited Hong Kong Sanatorium & Hospital
In March 2025, Professor Qian Chaonan, Dean of Guangzhou Concord Cancer Center, led a delegation to visit Hong Kong Sanatorium & Hospital and was received by the hospital. The visiting group toured multiple departments of Hong Kong Sanatorium & Hospital...
Representatives from National Cancer Centre Singapore Visits Guangzhou Concord Cancer Center
On March 9, 2025, Professor Toh Han Chong, Deputy CEO of National Cancer Centre Singapore (NCCS), visited Guangzhou Concord Cancer Center (GCCC)...
International Forum on Cutting - edge Proton Radiotherapy Technology Successfully Held: Gathering of Chinese and Foreign Experts, Integration of Research and Clinical Practice
On December 21, 2024, the International Forum on Cutting-edge Proton Radiotherapy Technology was held at Guangzhou Concord Cancer Center. Experts from China and the U.S., including those from Mayo Clinic and Johns Hopkins...
Ten Years of Collaboration: Concord Healthcare Group and MD Anderson Cancer Center Set an Example of International Cooperation in the Medical Industry
Concord Healthcare Group and MD Anderson Cancer Center marked their 10th collaboration anniversary in 2024, showcasing achievements at the 2024 Guangdong-Hong Kong-Macau Oncology Forum...
Treatment Strategies | The 2024 Guangdong-Hong Kong-Macao Greater Bay Area International Oncology Forum Concludes Successfully
From November 2nd to 3rd, 2024, the Guangdong-Hong Kong-Macao Greater Bay Area International Oncology Forum was held online, academically supported by MD Anderson and hosted by Concord Healthcare Group. Experts from MD Anderson and Chinese institutions discussed cutting-edge topics like AI in oncology...
Consul General of Indonesia in Guangzhou Visits Guangzhou Concord Cancer Center
On October 13, 2022, Mr. Ben Perkasa Drajat, Consul General of Indonesia in Guangzhou, accompanied by Socio-Cultural Consul Mr. Kurniawan Wibowo, visited Guangzhou Concord Cancer Center (GCCC) for an official inspection. The delegation was welcomed by Professor Qian Chaonan, President of GCCC, and toured key departments, ...